Randomised Controlled TrialtcVNSn = 33

Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson's disease: a double-blind, randomised sham-controlled proof-of-concept study

Sigurdsson HP, Hunter H, Alcock L, Maughan EE, Bramley H, Brown P, Palermo G, Baker MR, Taylor JP, Rochester L, et al.

Journal of Neurology · 2025

Key finding

Multi-dose cervical tcVNS was safe and tolerable but had minimal, non-significant effects on gait and cognition versus sham.

Condition
Parkinson's Disease
Stimulation
tcVNS
Evidence tier
Randomised Controlled Trial
Participants
33
View on DOI

Cite this study

Sigurdsson, H. P., Hunter, H., Alcock, L., Maughan, E. E., Bramley, H., Brown, P., Palermo, G., Baker, M. R., Taylor, J. P., Rochester, L., & Yarnall, A. J. (2025). Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson's disease: a double-blind, randomised sham-controlled proof-of-concept study. Journal of Neurology, 272(10). https://doi.org/10.1007/s00415-025-13430-4

Related studies in Parkinson's Disease

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.